X chromosome inactivation ratios in female carriers of X-linked sideroblastic anemia-Reference-Cited by-同舟云学术

X chromosome inactivation ratios in female carriers of X-linked sideroblastic anemia

Published:2001-06-15 Issue:12 Volume:97 Page:4000-4002
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Aivado Manuel¹,Gattermann Norbert¹,Bottomley Sylvia¹

Affiliation:

1. Correspondence: Manuel Aivado, Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine University, Moorenstrasse 5, Düsseldorf 40225, Germany

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/97/12/4000/1675509/h8120103998b.pdf

Reference9 articles.

1. Genetic control of X inactivation and processes leading to X-inactivation skewing.;Belmont;Am J Hum Genet.,1996

2. X- linked sideroblastic anemia in ten female probands due to ALAS2 mutations and skewed X chromosome inactivation [abstract].;Bottomley;Am J Hum Genet.,1998

3. Skewed X-chromosome inactivation promotes disease manifestation in female members of a family with X-linked sideroblastic anemia [abstract].;Aivado;Blood.,1999

4. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females.;Cazzola;Blood.,2000

5. Rapid and accurate identification of Staphylococcus Species by tRNA intergenic spacer length polymorphism analysis.;Maes;J Clin Microbiol.,1997

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options

;Journal of Blood Medicine;2020-09

2. Emerging therapies in β-thalassemia: toward a new era in management;Expert Opinion on Emerging Drugs;2020-04-02

3. The molecular genetics of sideroblastic anemia;Blood;2019-01-03

4. X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations;American Journal of Hematology;2013-11-20

5. The Role of the Immune System in Myelodysplasia: Implications for Therapy;Seminars in Hematology;2008-01